Back to top
Merck & Co. (MRK)
(Delayed Data from NYSE)
$103.75 USD
103.75
7,529,972
-0.13 (-0.13%)
Updated Dec 8, 2023 04:00 PM ET
After-Market: $103.56 -0.19 (-0.18%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
View All Zacks #1 Ranked Stocks
Cash flow Statements
Annual Cash Flow Statement
Fiscal Year End for Merck & Co, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Cash Flow From Operations, Investments & Financial Activities |
|||||
| Net Income (Loss) | 14,526.00 | 12,358.00 | 7,082.00 | 9,777.00 | 6,193.00 |
| Depreciation/Amortization & Depletion | 3,909.00 | 3,214.00 | 3,625.00 | 3,652.00 | 4,519.00 |
| Net Change from Assets/Liabilities | -2,782.00 | -3,839.00 | -4,590.00 | -2,067.00 | -1,553.00 |
| Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Activities | 3,442.00 | 1,389.00 | 4,136.00 | 2,078.00 | 1,763.00 |
| Net Cash From Operating Activities | 19,095.00 | 13,122.00 | 10,253.00 | 13,440.00 | 10,922.00 |
| Property & Equipment | -4,388.00 | -4,448.00 | -4,684.00 | -3,473.00 | -2,615.00 |
| Acquisition/ Disposition of Subsidiaries | -121.00 | -12,907.00 | -6,606.00 | -4,954.00 | -431.00 |
| Investments | -483.00 | 1,025.00 | 2,717.00 | 5,420.00 | 7,258.00 |
| Other Investing Activities | 32.00 | -91.00 | -870.00 | 378.00 | 102.00 |
| Net Cash from Investing Activities | -4,960.00 | -16,421.00 | -9,443.00 | -2,629.00 | 4,314.00 |
Uses of Funds
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Issuance (Repurchase) of Capital Stock | 384.00 | -638.00 | -1,192.00 | -4,419.00 | -8,500.00 |
| Issuance (Repayment) of Debt | -2,251.00 | 5,617.00 | 2,462.00 | 4,958.00 | -4,287.00 |
| Increase (Decrease) Short-Term Debt | 0.00 | -3,986.00 | 2,549.00 | -3,710.00 | 5,124.00 |
| Payment of Dividends & Other Distributions | -7,012.00 | -6,610.00 | -6,215.00 | -5,695.00 | -5,172.00 |
| Other Financing Activities | -240.00 | 8,714.00 | -436.00 | 5.00 | -325.00 |
| Net Cash from Financing Activities | -9,119.00 | 3,097.00 | -2,832.00 | -8,861.00 | -13,160.00 |
| Effect of Exchange Rate Changes | -410.00 | 216.00 | 253.00 | 17.00 | -205.00 |
| Net Change In Cash & Equivalents | 4,606.00 | 14.00 | -1,769.00 | 1,967.00 | 1,871.00 |
| Cash at Beginning of Period | 8,167.00 | 8,153.00 | 9,934.00 | 7,967.00 | 6,096.00 |
| Cash at End of Period | 12,773.00 | 8,167.00 | 8,165.00 | 9,934.00 | 7,967.00 |
| Diluted Net EPS | 5.71 | 5.14 | 2.78 | 3.81 | 2.32 |